These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 2313360)

  • 1. Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragment.
    Yokoyama K; Reynolds JC; Paik CH; Sood VK; Maloney PJ; Larson SM; Reba RC
    J Nucl Med; 1990 Feb; 31(2):202-10. PubMed ID: 2313360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma localization in nude mice with monoclonal Fab against p97.
    Beaumier PL; Krohn KA; Carrasquillo JA; Eary J; Hellström I; Hellström KE; Nelp WB; Larson SM
    J Nucl Med; 1985 Oct; 26(10):1172-9. PubMed ID: 4045562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
    Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
    J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biodistribution of 791T/36 monoclonal antibody and its Fab/c fragment in BALB/c mice and nude mice bearing human tumor xenografts.
    Demignot S; Pimm MV; Baldwin RW
    Cancer Res; 1990 May; 50(10):2936-42. PubMed ID: 2334894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
    Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
    Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
    Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
    J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of melanoma with L-131-labeled monoclonal antibodies.
    Larson SM; Brown JP; Wright PW; Carrasquillo JA; Hellström I; Hellström KE
    J Nucl Med; 1983 Feb; 24(2):123-9. PubMed ID: 6822875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody.
    Ghose T; Ferrone S; Imai K; Norvell ST; Luner SJ; Martin RH; Blair AH
    J Natl Cancer Inst; 1982 Oct; 69(4):823-6. PubMed ID: 6956760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
    Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
    Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma: the development of immunoconjugates from a preclinical viewpoint.
    Beaumier PL; Morgan AC; Woodhouse CS; Marchitto KS
    Immunol Ser; 1990; 53():297-316. PubMed ID: 2100562
    [No Abstract]   [Full Text] [Related]  

  • 11. Athymic rats in preclinical immunodiagnostic studies.
    Storeng RT; Kjønniksen I; Pihl A; Haug E; Fodstad O
    Anticancer Res; 1991; 11(2):649-55. PubMed ID: 2064318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM; Motta-Hennessy C; Pawlyk D; Siegel JA; Goldenberg DM
    Cancer Res; 1990 Apr; 50(8):2330-6. PubMed ID: 2180566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA.
    Matzku S; Kirchgessner H; Schmid U; Temponi M; Ferrone S
    J Nucl Med; 1989 Mar; 30(3):390-7. PubMed ID: 2472474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
    Beyers M; Aspinall S; Conradie JD; Fourie PJ
    Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
    Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
    Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
    Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
    Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.
    Stuhlmiller GM; Sullivan DC; Vervaert CE; Croker BP; Harris CC; Seigler HF
    Ann Surg; 1981 Nov; 194(5):592-601. PubMed ID: 6895297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
    Adams GP; Schier R; Marshall K; Wolf EJ; McCall AM; Marks JD; Weiner LM
    Cancer Res; 1998 Feb; 58(3):485-90. PubMed ID: 9458094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.
    Demignot S; Pimm MV; Thorpe SR; Baldwin RW
    Cancer Immunol Immunother; 1991; 33(6):359-66. PubMed ID: 1878889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.